SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367920-20-000039
Filing Date
2020-08-06
Accepted
2020-08-06 07:21:06
Documents
65
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cnce-20200630.htm   iXBRL 10-Q 1880099
2 EX-31.1 q22020exhibit311.htm EX-31.1 12881
3 EX-31.2 q22020exhibit312.htm EX-31.2 12846
4 EX-32.1 q22020exhibit321.htm EX-32.1 7951
5 EX-32.2 q22020exhibit322.htm EX-32.2 7874
9 cnce-20200630_g1.jpg GRAPHIC 137871
  Complete submission text file 0001367920-20-000039.txt   7263326

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnce-20200630.xsd EX-101.SCH 35723
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnce-20200630_cal.xml EX-101.CAL 69826
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnce-20200630_def.xml EX-101.DEF 195410
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnce-20200630_lab.xml EX-101.LAB 522938
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnce-20200630_pre.xml EX-101.PRE 327714
12 EXTRACTED XBRL INSTANCE DOCUMENT cnce-20200630_htm.xml XML 1184034
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36310 | Film No.: 201079810
SIC: 2834 Pharmaceutical Preparations